Showing results (81-90 of 238) with videos related to

Sort By:
Pageof 24
Lancet (London, England)|June 28, 2016
Bladder cancerAshish M Kamat, Noah M Hahn, Jason A Efstathiou, et al.
Urology|August 15, 2006
Prostate-specific antigen-based serial screening may decrease prostate cancer-specific mortalityJason A Efstathiou, Ming-Hui Chen, William J Catalona, et al.
Seminars in Radiation Oncology|December 14, 2022
Multidisciplinary Management and Radiotherapy Recommendations for Clinically and Pathologically Node-positive Bladder CancerBhanuPrasad Venkatesulu, Stanley L Liauw, Monika Joshi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2014
Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233Raymond H Mak, Daniel Hunt, William U Shipley, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2016
Disruption of SLX4-MUS81 Function Increases the Relative Biological Effectiveness of Proton RadiationQi Liu, Tracy S A Underwood, Jong Kung, et al.
Plos One|November 30, 2018
Long-term impact of a faculty mentoring program in academic medicineJason A Efstathiou, Michael R Drumm, Jonathan P Paly, et al.
Urologic Oncology|February 1, 2023
Bladder only versus bladder plus pelvic lymph node chemoradiation for muscle-invasive bladder cancerSagar A Patel, Yuan Liu, Abhishek A Solanki, et al.
International Journal of Radiation Oncology, Biology, Physics|October 16, 2010
Interfractional variations in the setup of pelvic bony anatomy and soft tissue, and their implications on the delivery of proton therapy for localized prostate cancerAlexei Trofimov, Paul L Nguyen, Jason A Efstathiou, et al.
Pageof 24